Study to Evaluate the Efficacy and Safety of SHR6390 Combined With Pyrotinib in HER2+ Advanced Breast Cancer
Clinical trial NCT04293276 · UNKNOWN
Trial details
- NCT number
- NCT04293276
- Sponsor
- Henan Cancer Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-04-01
- Primary completion
- 2021-08-23
- Enrollment
- 41
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.